Open Access 01-12-2019 | Dapagliflozin | Commentary
Report from the 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
Published in: Cardiovascular Diabetology | Issue 1/2019
Login to get access